Antidepressant augmentation: conclusions and recommendations.
Sussman
N
N
Department of Psychiatry, New York University School of Medicine, New York 10021, USA.
Joffe
R T
RT
D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000494:pharmacology / Q000627:therapeutic use; D002065:Buspirone / Q000494:pharmacology / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000494:pharmacology / Q000627:therapeutic use; D010869:Pindolol / Q000494:pharmacology / Q000627:therapeutic use; D014284:Triiodothyronine / Q000494:pharmacology / Q000627:therapeutic use
D000927:Anticonvulsants; D000928:Antidepressive Agents; D014284:Triiodothyronine; D001569:Benzodiazepines; D008094:Lithium; D010869:Pindolol; D002065:Buspirone